tiprankstipranks
Henry Schein (HSIC)
NASDAQ:HSIC
US Market
HSIC
Henry Schein
RESEARCH TOOLSreports
Want to see HSIC full AI Analyst Report?

Henry Schein (HSIC) Stock Forecast & Price Target

414 Followers
See the Price Targets and Ratings of:

HSIC Analyst Ratings

Moderate Buy
16Ratings
Moderate Buy
8 Buy
7 Hold
1 Sell
Based on 16 analysts giving stock ratings to
Henry
Schein
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

HSIC Stock 12 Month Forecast

Average Price Target

$87.43
▲(10.91% Upside)
Based on 16 Wall Street analysts offering 12 month price targets for Henry Schein in the last 3 months. The average price target is $87.43 with a high forecast of $100.00 and a low forecast of $64.00. The average price target represents a 10.91% change from the last price of $78.83.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"62":"$62","101":"$101","71.75":"$71.8","81.5":"$81.5","91.25":"$91.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$100.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":87.42857142857143,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$87.43</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":64,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$64.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[62,71.75,81.5,91.25,101],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.93,75.93538461538462,77.94076923076923,79.94615384615385,81.95153846153846,83.95692307692308,85.96230769230769,87.96769230769232,89.97307692307692,91.97846153846154,93.98384615384614,95.98923076923077,97.99461538461539,{"y":100,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.93,74.96835164835166,76.00670329670331,77.04505494505496,78.0834065934066,79.12175824175824,80.1601098901099,81.19846153846154,82.2368131868132,83.27516483516484,84.31351648351648,85.35186813186813,86.39021978021978,{"y":87.42857142857143,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.93,73.16615384615385,72.4023076923077,71.63846153846154,70.8746153846154,70.11076923076924,69.34692307692308,68.58307692307693,67.81923076923077,67.05538461538461,66.29153846153847,65.5276923076923,64.76384615384616,{"y":64,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":64.46,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.56,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.48,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.98,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.39,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.6,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.11,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.58,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.31,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.37,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.04,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.93,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$100.00Average Price Target$87.43Lowest Price Target$64.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on HSIC
Allen Lutz
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
05/14/26
Analysts Offer Insights on Healthcare Companies: Henry Schein (NASDAQ: HSIC), Insulet (NASDAQ: PODD) and Gilead Sciences (NASDAQ: GILD)
Barclays Analyst forecast on HSIC
Glen Santangelo
Barclays
Barclays
$86
Buy
9.10%
Upside
Assigned
05/07/26
Analysts Offer Insights on Healthcare Companies: Lemaitre Vascular (NASDAQ: LMAT), Henry Schein (NASDAQ: HSIC) and Exelixis (NASDAQ: EXEL)
Robert W. Baird Analyst forecast on HSIC
Jeff Johnson
Robert W. Baird
Robert W. Baird
$104→$97
Buy
23.05%
Upside
Reiterated
05/06/26
Henry Schein price target lowered to $97 from $104 at BairdHenry Schein price target lowered to $97 from $104 at Baird
Stifel Nicolaus Analyst forecast on HSIC
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
$84
Hold
6.56%
Upside
Reiterated
05/06/26
Stifel Nicolaus Keeps Their Hold Rating on Henry Schein (HSIC)
UBS Analyst forecast on HSIC
Kevin Caliendo
UBS
UBS
$87→$85
Hold
7.83%
Upside
Reiterated
05/06/26
Henry Schein price target lowered to $85 from $87 at UBSHenry Schein price target lowered to $85 from $87 at UBS
Mizuho Securities Analyst forecast on HSIC
Steven Valiquette
Mizuho Securities
Mizuho Securities
$88→$82
Hold
4.02%
Upside
Reiterated
05/06/26
Henry Schein price target lowered to $82 from $88 at MizuhoHenry Schein price target lowered to $82 from $88 at Mizuho
Barrington Analyst forecast on HSIC
Michael Petusky
Barrington
Barrington
$97
Buy
23.05%
Upside
Reiterated
05/06/26
Analysts Are Bullish on Top Healthcare Stocks: Henry Schein (HSIC), Alphatec Holdings (ATEC)
Morgan Stanley Analyst forecast on HSIC
Erin Wright
Morgan Stanley
Morgan Stanley
$61→$64
Sell
-18.81%
Downside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (NASDAQ: RYTM), Henry Schein (NASDAQ: HSIC) and Ultragenyx Pharmaceutical (NASDAQ: RARE)
Evercore ISI Analyst forecast on HSIC
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$90
Buy
14.17%
Upside
Reiterated
05/05/26
Evercore ISI Remains a Buy on Henry Schein (HSIC)
William Blair Analyst forecast on HSIC
Brandon Vazquez
William Blair
William Blair
$74
Hold
-6.13%
Downside
Reiterated
05/05/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Henry Schein (NASDAQ: HSIC), Viridian Therapeutics (NASDAQ: VRDN) and Q32 Bio (NASDAQ: QTTB)
BTIG Analyst forecast on HSIC
David Larsen
BTIG
BTIG
―
Hold
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (NASDAQ: QDEL), Climb Bio (NASDAQ: CLYM) and Henry Schein (NASDAQ: HSIC)
Piper Sandler Analyst forecast on HSIC
Jason Bednar
Piper Sandler
Piper Sandler
$99
Buy
25.59%
Upside
Reiterated
05/04/26
Piper Sandler Reaffirms Their Buy Rating on Henry Schein (HSIC)
Citi Analyst forecast on HSIC
Daniel Grosslight
Citi
Citi
$100
Buy
26.86%
Upside
Initiated
04/16/26
Henry Schein initiated with a Buy at CitiHenry Schein initiated with a Buy at Citi
Wells Fargo Analyst forecast on HSIC
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
$76→$87
Hold
10.36%
Upside
Reiterated
02/25/26
Wells Fargo Reaffirms Their Hold Rating on Henry Schein (HSIC)
J.P. Morgan Analyst forecast on HSIC
John Stansel
J.P. Morgan
J.P. Morgan
$78→$92
Buy
16.71%
Upside
Reiterated
02/25/26
Henry Schein price target raised to $92 from $78 at JPMorganHenry Schein price target raised to $92 from $78 at JPMorgan
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on HSIC
Allen Lutz
Bank of America Securities
Bank of America Securities
―
Buy
―
Reiterated
05/14/26
Analysts Offer Insights on Healthcare Companies: Henry Schein (NASDAQ: HSIC), Insulet (NASDAQ: PODD) and Gilead Sciences (NASDAQ: GILD)
Barclays Analyst forecast on HSIC
Glen Santangelo
Barclays
Barclays
$86
Buy
9.10%
Upside
Assigned
05/07/26
Analysts Offer Insights on Healthcare Companies: Lemaitre Vascular (NASDAQ: LMAT), Henry Schein (NASDAQ: HSIC) and Exelixis (NASDAQ: EXEL)
Robert W. Baird Analyst forecast on HSIC
Jeff Johnson
Robert W. Baird
Robert W. Baird
$104→$97
Buy
23.05%
Upside
Reiterated
05/06/26
Henry Schein price target lowered to $97 from $104 at BairdHenry Schein price target lowered to $97 from $104 at Baird
Stifel Nicolaus Analyst forecast on HSIC
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
$84
Hold
6.56%
Upside
Reiterated
05/06/26
Stifel Nicolaus Keeps Their Hold Rating on Henry Schein (HSIC)
UBS Analyst forecast on HSIC
Kevin Caliendo
UBS
UBS
$87→$85
Hold
7.83%
Upside
Reiterated
05/06/26
Henry Schein price target lowered to $85 from $87 at UBSHenry Schein price target lowered to $85 from $87 at UBS
Mizuho Securities Analyst forecast on HSIC
Steven Valiquette
Mizuho Securities
Mizuho Securities
$88→$82
Hold
4.02%
Upside
Reiterated
05/06/26
Henry Schein price target lowered to $82 from $88 at MizuhoHenry Schein price target lowered to $82 from $88 at Mizuho
Barrington Analyst forecast on HSIC
Michael Petusky
Barrington
Barrington
$97
Buy
23.05%
Upside
Reiterated
05/06/26
Analysts Are Bullish on Top Healthcare Stocks: Henry Schein (HSIC), Alphatec Holdings (ATEC)
Morgan Stanley Analyst forecast on HSIC
Erin Wright
Morgan Stanley
Morgan Stanley
$61→$64
Sell
-18.81%
Downside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (NASDAQ: RYTM), Henry Schein (NASDAQ: HSIC) and Ultragenyx Pharmaceutical (NASDAQ: RARE)
Evercore ISI Analyst forecast on HSIC
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$90
Buy
14.17%
Upside
Reiterated
05/05/26
Evercore ISI Remains a Buy on Henry Schein (HSIC)
William Blair Analyst forecast on HSIC
Brandon Vazquez
William Blair
William Blair
$74
Hold
-6.13%
Downside
Reiterated
05/05/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Henry Schein (NASDAQ: HSIC), Viridian Therapeutics (NASDAQ: VRDN) and Q32 Bio (NASDAQ: QTTB)
BTIG Analyst forecast on HSIC
David Larsen
BTIG
BTIG
―
Hold
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (NASDAQ: QDEL), Climb Bio (NASDAQ: CLYM) and Henry Schein (NASDAQ: HSIC)
Piper Sandler Analyst forecast on HSIC
Jason Bednar
Piper Sandler
Piper Sandler
$99
Buy
25.59%
Upside
Reiterated
05/04/26
Piper Sandler Reaffirms Their Buy Rating on Henry Schein (HSIC)
Citi Analyst forecast on HSIC
Daniel Grosslight
Citi
Citi
$100
Buy
26.86%
Upside
Initiated
04/16/26
Henry Schein initiated with a Buy at CitiHenry Schein initiated with a Buy at Citi
Wells Fargo Analyst forecast on HSIC
Unknown Analyst
Wells Fargo
Not Ranked
Wells Fargo
$76→$87
Hold
10.36%
Upside
Reiterated
02/25/26
Wells Fargo Reaffirms Their Hold Rating on Henry Schein (HSIC)
J.P. Morgan Analyst forecast on HSIC
John Stansel
J.P. Morgan
J.P. Morgan
$78→$92
Buy
16.71%
Upside
Reiterated
02/25/26
Henry Schein price target raised to $92 from $78 at JPMorganHenry Schein price target raised to $92 from $78 at JPMorgan
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Henry Schein

3 Months
Michael PetuskyBarrington
Success Rate
20/37 ratings generated profit
54%
Average Return
+1.68%
Copying Michael Petusky's trades and holding each position for 3 Months would result in 54.05% of your transactions generating a profit, with an average return of +1.68% per trade.
1 Year
Allen LutzBank of America Securities
Success Rate
8/15 ratings generated profit
53%
Average Return
+0.81%
Copying Allen Lutz's trades and holding each position for 1 Year would result in 53.33% of your transactions generating a profit, with an average return of +0.81% per trade.
2 Years
Allen LutzBank of America Securities
Success Rate
6/15 ratings generated profit
40%
Average Return
-2.36%
Copying Allen Lutz's trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of -2.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HSIC Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
12
12
14
12
12
Hold
5
9
11
10
8
Sell
1
1
1
2
2
Strong Sell
0
0
0
0
0
total
18
22
26
24
22
In the current month, HSIC has received 12 Buy Ratings, 8 Hold Ratings, and 2 Sell Ratings. HSIC average Analyst price target in the past 3 months is 87.43.
Each month's total comprises the sum of three months' worth of ratings.

HSIC Financial Forecast

HSIC Earnings Forecast

Next quarter’s earnings estimate for HSIC is $1.23 with a range of $1.12 to $1.37. The previous quarter’s EPS was $1.32. HSIC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year HSIC has Performed in-line its overall industry.
Next quarter’s earnings estimate for HSIC is $1.23 with a range of $1.12 to $1.37. The previous quarter’s EPS was $1.32. HSIC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year HSIC has Performed in-line its overall industry.

HSIC Sales Forecast

Next quarter’s sales forecast for HSIC is $3.38B with a range of $3.35B to $3.41B. The previous quarter’s sales results were $3.37B. HSIC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year HSIC has Performed in-line its overall industry.
Next quarter’s sales forecast for HSIC is $3.38B with a range of $3.35B to $3.41B. The previous quarter’s sales results were $3.37B. HSIC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year HSIC has Performed in-line its overall industry.

HSIC Stock Forecast FAQ

What is HSIC’s average 12-month price target, according to analysts?
Based on analyst ratings, Henry Schein’s 12-month average price target is 87.43.
    What is HSIC’s upside potential, based on the analysts’ average price target?
    Henry Schein has 10.91% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is HSIC a Buy, Sell or Hold?
          Henry Schein has a consensus rating of Moderate Buy which is based on 8 buy ratings, 7 hold ratings and 1 sell ratings.
            What is Henry Schein’s price target?
            The average price target for Henry Schein is 87.43. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $100.00 ,the lowest forecast is $64.00. The average price target represents 10.91% Increase from the current price of $78.83.
              What do analysts say about Henry Schein?
              Henry Schein’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 16 Wall Streets Analysts.
                How can I buy shares of HSIC?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.